PLAT and age-related macular degeneration: Included in this study were a total of 115 patients who presented to the Department of Ophthalmology, University of Bonn, Germany, with a SMH due to AMD and who received either an intravitreal injection of recombinant tPA, bevacizumab, and gas tamponade or ppV with subretinal rTPA administration and intravitreal bevacizumab injection, followed by gas tamponade.